A collection of multiple rod-shaped chemical vaporizers

Abstract

To provide an assembled body of a plurality of rod-like chemical volatilizing bodies that can be produced at a low cost.SOLUTION: An assembled body 20 is constituted of a piece of cardboard 22 that has six chemical volatilizing bodies 16 and extends on a plane. The cardboard 22 exhibits a rectangular form consisting of a pair of short sides 2002 and a pair of long sides 2004, in a plan view. The six chemical volatilizing bodies 16 are arranged in a direction orthogonal to their length L direction while their length L direction is made parallel in the cardboard 22. The six chemical volatilizing bodies 16 are arranged such that side faces of the chemical volatilizing bodies 16 positioned at both ends in a width W direction face with each other. The side faces of the adjacent chemical volatilizing bodies 16 are connected by cut-off parts 24 that can be cut off, and the cut-off parts 24 linearly extend in the length L direction.SELECTED DRAWING: Figure 3

Description

[Technical Field]

[0001] The present invention relates to an assembly of a plurality of rod-shaped pharmaceutical volatilizers. [Background technology]

[0002] Various types of drug volatilizers have been provided in the past, and Patent Documents 1, 2, 3, and 4 provide a drug volatilizer that includes a container having an opening at the top for containing a volatile drug, and a plurality of rod-shaped drug volatilizers that are inserted into the container through the opening, with their lower parts immersed in the drug and their upper parts protruding above the container from the opening. In a drug volatilizer that uses a rod-shaped drug volatilizer, the drug inside the container is sucked up by the drug volatilizer, and the drug is volatilized from the part of the drug volatilizer that protrudes upward from the container. Rod-shaped chemical volatilizers made of wood, rattan, bamboo, and resin are available. [Prior art documents] [Patent documents]

[0003] [Patent Document 1] Japanese Patent Publication No. 2020-188974 [Patent Document 2] Patent Publication No. 2021-176537 [Patent Document 3] Utility Model Registration No. 3119834 [Patent Document 4] Japanese Patent Application Laid-Open No. 2011-212271 Summary of the Invention [Problem to be solved by the invention]

[0004] On the other hand, when using such rod-shaped drug volatilizers, multiple rod-shaped drug volatilizers are packed in a box or the like along with the container containing the drug and then distributed to the market.However, if multiple rod-shaped drug volatilizers are separated into pieces, they will look unsightly when removed from the box, reducing their commercial value. Therefore, conventionally, the number of rod-shaped chemical volatilizers is accurately counted and sealed in a transparent bag, or they are bound together with a binding device and placed in a box together with the container, packaged, and distributed to the market. However, the task of gathering multiple rod-shaped drug volatilizers together is time-consuming, which has the drawback of making the drug volatilizer expensive. The present invention was devised in view of the above circumstances, and an object of the present invention is to provide an assembly of multiple rod-shaped drug volatilizers that can be manufactured easily and at low cost. [Means for solving the problem]

[0005] In order to achieve the above-mentioned object, one embodiment of the present invention is an assembly of multiple rod-shaped drug volatilizers that volatilize a drug, wherein the assembly is formed from a single thin plate-shaped substrate, the multiple drug volatilizers are arranged within the substrate with their length directions parallel to each other and in a direction perpendicular to the length direction, and adjacent drug volatilizers are connected to each other by detachable detachment portions. In addition, one embodiment of the present invention is characterized in that the cross section of the drug volatilizer cut in a plane perpendicular to its longitudinal direction has a flat rectangular shape with a width greater than its thickness, and the multiple drug volatilizers have sides facing each other at both ends in the width direction, and the separation portion connects the facing sides. In addition, one embodiment of the present invention is characterized in that the base is rectangular in plan view, the multiple drug volatilizers are arranged on the base via the separation portions, and both longitudinal ends of the multiple drug volatilizers are located on a pair of short sides of the rectangle. In addition, one embodiment of the present invention is characterized in that the drug volatilizer is made of cardboard, and the base is also formed of cardboard. In addition, one embodiment of the present invention is characterized in that the separation portion is configured to include a breakable connection portion that connects adjacent drug volatilizers to each other, and a slit that separates adjacent drug volatilizers from each other. In addition, one embodiment of the present invention is characterized in that the multiple rod-shaped drug volatilizers are used as drug volatilizers in which one end of each drug volatilizer is inserted into a container containing a volatile drug and the other end of each drug volatilizer protrudes above the container, and the connection portion is provided only at the location of the drug volatilizer that is inserted into the container. In addition, one embodiment of the present invention is characterized in that the connection portions are provided at two locations: at the longitudinal end of the drug volatilizer and at a location 1 / 3 of the total length of the drug volatilizer from the longitudinal end of the drug volatilizer, and when the thickness of the drug volatilizer is 0.4 mm to 0.6 mm, the lengths of the connection portions provided at the two locations along the longitudinal direction of the drug volatilizer are both approximately 0.5 mm. In addition, one embodiment of the present invention is characterized in that the multiple rod-shaped drug volatilizers are used as a drug volatilizer in which one longitudinal end of the drug volatilizers is inserted into a container containing a volatile drug and the other longitudinal end of the drug volatilizers protrudes above the container, and the connection portion is provided at the location of the drug volatilizer inserted into the container and at the location of the drug volatilizer protruding from the container, and the length along the longitudinal direction of the drug volatilizer of the connection portion provided at the location of the drug volatilizer protruding from the container is formed to be shorter than the length along the longitudinal direction of the drug volatilizer of the connection portion provided at the location of the drug volatilizer inserted into the container. In addition, one embodiment of the present invention is characterized in that the connection portion provided at the location of the drug volatilizer inserted into the container is provided at two locations: one end of the drug volatilizer in the longitudinal direction and one third of the total length of the drug volatilizer from one end of the drug volatilizer in the longitudinal direction; the connection portion provided at the location of the drug volatilizer protruding from the container is provided at one location near the other end of the drug volatilizer in the longitudinal direction; when the thickness of the drug volatilizer is 0.4 mm to 0.6 mm, the length of the connection portion provided at one end of the drug volatilizer in the longitudinal direction inserted into the container is approximately 0.5 mm, the length of the connection portion inserted into the container and provided at a location 1 / 3 of the total length of the drug volatilizer from the one end is approximately 0.4 mm, and the length of the connection portion provided at a location near the other end of the drug volatilizer in the longitudinal direction protruding from the container is approximately 0.3 mm. [Effects of the Invention]

[0006] According to one embodiment of the assembly of the present invention, since the base is punched out with a blade die to produce the assembly at the same time as the drug volatilizer is produced, or since the assembly is produced using a molding machine to produce the assembly at the same time as the drug volatilizer is produced, an assembly in which multiple rod-shaped drug volatilizers are arranged in a detachable manner to form a single component can be produced easily and reliably at low cost. Therefore, it is possible to eliminate the conventional work of accurately counting the number of rod-shaped drug volatilizers and sealing them in a transparent bag, or the time-consuming work of binding multiple rod-shaped drug volatilizers with a binding device, and it is possible to easily manufacture an assembly of multiple rod-shaped drug volatilizers at low cost, which is advantageous in reducing the cost of drug volatilizers using multiple drug volatilizers and in increasing the sales volume of drug volatilizers using multiple drug volatilizers. Furthermore, according to the assembly of one embodiment of the present invention, it is advantageous in that it allows for the easy production of an assembly of drug volatilizers that have excellent designability and are easy to print patterns on, and that have a rectangular cross section and extend in an elongated shape. Furthermore, according to an embodiment of the assembly of the present invention, when the assembly is formed from a single base that is flat, thin, and rectangular in plan view, the assembly is not bulky and does not require a large space to be secured, so it can be easily inserted into a box together with the container, allowing the packaging box to be kept to a minimum size, which is advantageous for reducing the cost of the drug volatilizer, is advantageous for increasing the sales volume of drug volatilizers that use multiple drug volatilizers, and is advantageous for easily manufacturing an assembly of drug volatilizers that have a rectangular cross section and extend in an elongated shape of the same length. According to one embodiment of the assembly of the present invention, if the drug volatilizer is made of cardboard, cardboard can be used as the base, and multiple assemblies can be produced efficiently and easily by punching out a single piece of cardboard with a Thomson blade die. In the present invention, various conventionally known materials such as wood, rattan, and bamboo can be used as drug volatilizers. However, using cardboard as a drug volatilizer eliminates multiple processing steps and dedicated molding machines compared to using drug volatilizers made of wood, rattan, bamboo, or resin. This is advantageous for achieving significant cost reductions in drug volatilizers and drug volatilizers while also being environmentally friendly, and is also advantageous for significantly increasing sales of drug volatilizers and drug volatilizers. In addition, using a cardboard material as the pesticide volatilizer makes the pesticide absorption and evaporation speeds almost uniform, ensuring that the pesticide evaporation effect is achieved, which is advantageous in increasing the practical and commercial value of the pesticide volatilizer. In addition, the separation portion of the present invention can employ various conventionally known structures, such as a structure in which a dotted line of perforations is formed at the point where the cardboard portions of adjacent drug volatilizers are connected, or a structure in which the point where the cardboard portions of adjacent drug volatilizers are connected is composed of a thin-walled portion that is thinner than the drug volatilizers.However, if the separation portion is composed of a combination of a breakable connection portion connecting the cardboard portions of adjacent drug volatilizers and a slit that separates adjacent drug volatilizers, then by punching out the cardboard with a Thomson blade, multiple assemblies can be easily and reliably produced at the same time as the drug volatilizers are produced, which is advantageous for producing assemblies at low cost. Furthermore, if the connection part is provided only at the part of the drug volatilizer that is inserted into the container, no unevenness will be created in the part of the drug volatilizer that protrudes from the container due to separation, and any unevenness that occurs when the connection part is broken will be less noticeable because it will be located inside the container, which is advantageous in terms of enhancing the design and aesthetics of the drug volatilizer. In this case, the connection parts can be provided at two locations: at the longitudinal end of the drug volatilizer and at a location 1 / 3 of the total length of the drug volatilizer from the longitudinal end of the drug volatilizer.If the thickness of the drug volatilizer is 0.4 mm to 0.6 mm, it is preferable that the lengths of the connection parts provided at both locations be approximately 0.5 mm. Furthermore, although a long connection part can prevent the drug volatilizer from breaking apart from the assembly due to vibration and impact during manufacturing and market distribution, when the drug volatilizer is separated, the unevenness caused by the connection part breaking will be noticeable, which is thought to be detrimental to enhancing the design of the drug volatilizer.Therefore, it is preferable that the length of the connection part provided at the part of the drug volatilizer that protrudes from the container be formed to be shorter than the length of the connection part provided at the part of the drug volatilizer that is inserted into the container. In this case, when the thickness of the drug volatilizer is 0.4 mm to 0.6 mm, the connectors provided at the part of the drug volatilizer inserted into the container are provided at two locations: one end of the drug volatilizer in the longitudinal direction and one third of the total length of the drug volatilizer from one end of the drug volatilizer in the longitudinal direction, and the connector provided at the part of the drug volatilizer protruding from the container is provided at one location closer to the other end of the drug volatilizer in the longitudinal direction. Preferably, the length of the connector provided at one end of the drug volatilizer in the longitudinal direction is about 0.5 mm, the length of the connector provided at the location one third of the total length of the drug volatilizer from one end is about 0.4 mm, and the length of the connector provided at the location closer to the other end of the drug volatilizer in the longitudinal direction protruding from the container is about 0.3 mm. [Brief explanation of the drawings]

[0007] [Figure 1] This is an oblique view of the drug volatilizer in use. [Figure 2] FIG. 1 is a perspective view of a drug volatilizer. [Figure 3] (A) and (B) are plan views of the assembly. [Figure 4] FIG. 10 is an explanatory diagram showing the manufacturing of multiple assemblies from one piece of cardboard. [Figure 5] FIG. [Figure 6] (A) and (B) are plan views of the assembly. [Figure 7] (A) and (B) are plan views of the assembly. [Figure 8] (A) and (B) are explanatory diagrams showing how to produce multiple assemblies from a single piece of cardboard. DETAILED DESCRIPTION OF THE INVENTION

[0008] First, we will explain a drug volatilizer that uses an assembly of multiple rod-shaped drug volatilizers, and then we will explain an embodiment of the present invention, which is an assembly of multiple drug volatilizers made of cardboard. As shown in Figure 1, the drug volatilizer 10 comprises a container 14 containing a volatile liquid drug 12, and a plurality of cardboard drug volatilizers 16 inserted into the container 14. As chemical 12, an aromatic substance, an insect repellent, an insecticide, or the like is used, and in this embodiment, chemical 12 is an aromatic substance 12A. The aromatic agent 12A is composed of a single fragrance component or a mixture of a fragrance component and a volatile solvent, and is a transparent liquid in this embodiment.

[0009] The container 14 is made of synthetic resin or glass, and is transparent in this embodiment. The container 14 contains the drug 12 and has a large diameter portion 1402 and a small diameter portion 1404 provided on top of the large diameter portion 1402, with the upper end of the small diameter portion 1404 forming a circular opening 1406. When the drug vaporizer 10 is distributed on the market, the container 14 contains an aromatic substance 12A as the drug 12, and a cap (not shown) is removably attached to the opening 1406. When the drug vaporizer 10 is used, the cap is removed from the opening 1406 and the container 14 is placed in an appropriate location.

[0010] The chemical volatilizer 16 has a long, thin rod shape and is inserted into the container 14 through the opening 1406, with the lower part immersed in the fragrance 12A inside the container 14 and the upper part protruding from the opening 1406 above the container 14. Chemical volatilizer 16 is a member that draws up aromatic substance 12A from the portion immersed in aromatic substance 12A by capillary action, and volatilizes aromatic substance 12A from the portion exposed above the liquid surface of aromatic substance 12A. The cross section of the drug volatilizer 16 may be circular or square, and various conventionally known shapes can be applied to the cross section of the drug volatilizer 16.

[0011] The drug volatilizer 16 is made of cardboard. Cardboard is thicker than commonly used paper, and paper is made by tightly intertwining plant fibers in water, stretching them into a thin, flat shape, and then dehydrating and drying them. There are no particular restrictions on the type of paper, and coated paper, fine paper, matte paper, art post paper, kraft paper, matte post paper, and Kent paper are used. In this embodiment, recycled paper (50% waste paper) is used. Recycled paper is made from recycled waste paper and is preferable from the perspective of forest environment conservation. In this embodiment, the drug volatilizer 16 extends in a strip shape with a flat rectangular cross section. In this embodiment, the drug volatilizer 16 has a uniform width W of about 5 mm, a length L of about 180 mm, and a uniform thickness T of about 0.5 mm, which is smaller than the width W, and extends linearly. The length L and width W of the drug volatilizer 16 are determined appropriately according to the size of the container 14, and the length L of the drug volatilizer 16 used in the present invention is 100 mm to 240 mm, the thickness T is 0.3 mm to 1 mm, and the width W is 3 mm to 10 mm. In addition, a pattern 18 is printed on one side of the drug volatilizer 16 in the length L direction on at least one of the two ends in the thickness T direction. Here, the design 18 is a concept including letters, patterns, characters, and the like. The ink used for printing is selected appropriately, but it is preferable to use a pigment so that it will not bleed due to the absorbed fragrance 12A. The printing method may be selected appropriately from offset printing, gravure printing, flexographic printing, and the like. As will be described later, the chemical volatilizer 16 is placed in the container 14 and used in an inclined position, so its cross-sectional area, length, and basis weight are appropriately determined so that it does not bend under its own weight when it absorbs the aromatic substance 12A. Furthermore, the basis weight of the chemical volatilizer 16 is appropriately determined so that it can absorb the aromatic substance 12A.

[0012] When not permeated with aromatic liquid 12A, medicinal volatilizer 16 exhibits a light color such as light blue, light yellow, light orange, light pink, light brown, or light gray, and when permeated with aromatic liquid 12A, these colors change to dark blue, dark yellow, dark orange, dark pink, dark brown, or dark gray, respectively. Pattern 18 is formed in a color close to the color of the medicinal volatilizer permeated with aromatic liquid 12A. In this embodiment, when the aromatic agent 12A has not permeated the drug volatilizer 16, it is light brown in color, and the pattern 18 is formed in dark brown, and when the aromatic agent 12A has permeated the drug volatilizer 16 changes color from light brown to dark brown, making the pattern 18 difficult to see. Furthermore, when the use of the chemical vaporizer 10 is finished and the aromatic substance 12A is used up, the chemical vaporizer 16 dries and turns light brown again, and the pattern 18 is formed so that it can be seen.

[0013] The method of using the chemical volatilizer 10 is as follows. The container 14 contains the aromatic substance 12A, and a cap is removably attached to the opening 1406. The container 14 and a plurality of the chemical volatilizers 16 are placed in a box, packaged, and distributed to the market. When using the drug volatilizer 10, the purchaser removes the cap from the opening 1406, places multiple drug volatilizers 16 into the container 14 through the opening 1406, and places the container 14 in an appropriate location. In this case, when the drug volatilizer 16 is first removed from the box, the pattern 18 printed on one side of the drug volatilizer 16 in the length L direction is visible, so the user places multiple drug volatilizers 16 into the container 14 through the opening 1406 so that the area where the pattern 18 is printed is positioned at the top of the container 14, and immerses their lower parts in the fragrance 12A.

[0014] Eventually, the aromatic substance 12A is absorbed by the chemical volatilizer 16, and the color of the chemical volatilizer 16 changes from light brown to dark brown from bottom to top, making the pattern 18 difficult to see. The aromatic components of the aromatic agent 12A are volatilized into the room from the locations of the plurality of chemical volatilizers 16 exposed above the liquid surface of the aromatic agent 12A. When the aromatic substance 12A in the container 14 is used up and the aromatic components of the aromatic substance 12A absorbed into the plurality of chemical volatilizers 16 are all volatilized, the chemical volatilizer 10 is no longer in use. When the use of the chemical volatilizer 10 is finished, the multiple chemical volatilizers 16 dry and return to a light brown color, and the pattern 18 becomes visible again, so the user can tell that the chemical volatilizer 10 has finished being used by looking at the pattern 18 on the chemical volatilizers 16 without looking at the remaining amount of the fragrance 12A in the container 14. In the present invention, various conventionally known materials can be used as materials for forming the drug volatilizer 16, but by making the drug volatilizer 16 from cardboard, the drug volatilizer 16 can be easily and reliably manufactured by cutting the cardboard, and compared to making the drug volatilizer 16 from wood, rattan, bamboo, or resin, multiple processing steps and dedicated molding machines can be omitted, which is advantageous for achieving significant cost reductions in the drug volatilizer 16 and drug volatilizer 10 while also being environmentally friendly, and is advantageous for significantly increasing the sales volume of the drug volatilizer 16 and drug volatilizer 10. Furthermore, when the pesticide volatilizer 16 is made of wood, rattan, or bamboo, there is variation in the absorption speed and evaporation speed due to the natural materials, but when the pesticide volatilizer 16 is made of cardboard, the absorption speed and evaporation speed of the pesticide 12 are almost uniform, ensuring the evaporation effect of the pesticide 12, which is advantageous in increasing the practical value and commercial value of the pesticide volatilizer 10. In addition, in this embodiment, the drug volatilizer 16 extends in a band shape with a flat rectangular cross section, which is advantageous in terms of improving the aesthetic appearance of the drug volatilizer 16 and the drug volatilizer 10. Furthermore, since the drug volatilizer 16 has a flat rectangular cross section, extends linearly in a band shape, and is formed from cardboard, a pattern 18 can be easily printed on the drug volatilizer 16, which is even more advantageous in enhancing the design and aesthetic appeal of the drug volatilizer 16 and the drug volatilizer 10. Furthermore, the pattern 18 is visible when the aromatic substance 12A has not soaked into the chemical volatilizer 16, becomes difficult to see when the chemical volatilizer 10 is in use, and becomes visible again when it is time to finish using it. Therefore, even if, for example, the container 14 is opaque and the remaining amount of aromatic substance 12A in the container 14 can only be seen from the opening 1406, the user can tell that the chemical volatilizer 10 has reached the end of its use by seeing the color of the chemical volatilizer 16 without having to see the remaining amount of aromatic substance 12A from the opening 1406, which is advantageous in improving the usability of the chemical volatilizer 10. Furthermore, if the drug volatilizer 16 is formed with a flat rectangular cross section, even if the container 14 tilts when the drug volatilizer 10 is moved to a different location or if the container 14 is vibrated when the drug volatilizer 10 is used in a car, the drug volatilizer 16 is less likely to rotate around its central axis within the container 14, and multiple drug volatilizers 16 are less likely to become crowded and stick together, which is advantageous in maintaining the volatility of the drug 12 and the design and aesthetics of the drug volatilizer 10.

[0015] Next, the assembly 20 of the chemical volatilizer 16 will be described. In this embodiment, six drug volatilizers 16 are used in the drug volatilizer 10. The drug volatilizers 16 extend linearly with a uniform width W (5 mm), uniform thickness T (0.5 mm), and uniform length L (180 mm). All six drug volatilizers 16 have the same shape, being elongated rectangles when viewed in a plane. As shown in Figures 3(A) and (B), the assembly 20 is composed of a base made of a single piece of cardboard 22 having six chemical volatilizers 16 and extending on a single plane. The cardboard 22 constituting the base has a rectangular shape consisting of a pair of short sides 2002 and a pair of long sides 2004 in plan view. The six chemical volatilizers 16 are arranged in the cardboard 22 in a direction perpendicular to the length L direction with their length L direction parallel to each other. In detail, the six drug volatilizers 16 are arranged between a pair of long sides 2002 of the rectangle with their length L direction parallel to the long sides 2002, their width W direction parallel to the short sides 2002 of the rectangle, and both ends of the length L direction of the six drug volatilizers 16 positioned on a pair of short sides 2002 of the rectangle; therefore, the thickness of the cardboard 22 is the thickness T of the drug volatilizers 16. The six drug volatilizers 16 are arranged so that the side surfaces of the drug volatilizers 16 located at both ends in the width W direction face each other.

[0016] The sides of adjacent drug volatilizers 16 are connected by a detachable separation section 24, which extends linearly in the length L direction. The separation portion 24 may be formed from a single connecting portion 24 in which a dotted line cut is made at the point where the cardboard portions of adjacent drug volatilizers 16 are connected to form a perforation. Alternatively, it may be formed by combining this connecting portion 24 with a cut 24B that separates adjacent drug volatilizers 16. Alternatively, the separation portion 24 may be formed from a single connecting portion 24 in which the point where the cardboard portions of adjacent drug volatilizers 16 are connected is made into a thin portion that is thinner than the drug volatilizers 16, or may be formed by combining this connecting portion 24 with a cut 24B. Various conventionally known structures can be used for the separation portion 24. In this embodiment, the separation portion 24 is composed of at least one rupturable connection portion 24A that is located at intervals in the length L direction and connects the cardboard portions of adjacent drug volatilizers 16, and a slit 24B that is located at a location other than the connection portion 24A and separates adjacent drug volatilizers 16 from each other. As shown in Figure 4, multiple assemblies 20 having such cut-off portions 24 are produced simultaneously with the production of the drug volatilizer 16 by punching out a single sheet of cardboard 2202 larger than cardboard 22 using a Thomson blade. Furthermore, by stacking multiple sheets of cardboard 2202 and punching them out using a Thomson blade, several times the amount of assemblies 20 can be produced in one punching process. A purchaser of the drug volatilizer 10 removes a single assembly 20 from the box, breaks the detachment portion 24 to separate six drug volatilizers 16 from the assembly 20, places the multiple drug volatilizers 16 into the container 14 through the opening 1406, and places the container 14 in an appropriate location to use the drug volatilizer 10. The drug volatilizer 16 can be separated from the assembly 20 by moving the drug volatilizer 16 located at the end of the assembly 20 in the direction of the width W of the drug volatilizer 16 away from the assembly 20, or by swinging the drug volatilizer 16 in a fan shape using the longitudinal end of the drug volatilizer 16 as a fulcrum, or by bending the drug volatilizer 16 so that it overlaps the assembly 20 side at the separation section 24 and separating it.

[0017] According to the assembly 20 of this embodiment, multiple rod-shaped drug volatilizers 16 are arranged in a detachable manner by punching out multiple sheets of cardboard 2202 stacked on top of each other with a Thomson blade, and multiple assemblies 20 each consisting of a single member whose connecting portion 24A will not break and whose drug volatilizers 16 will not come apart due to vibrations or impacts during manufacturing or transportation are manufactured simultaneously when manufacturing the drug volatilizers 16, so that the assembly 20 can be manufactured easily and reliably at low cost. Therefore, it is possible to omit the conventional work of enclosing multiple rod-shaped drug volatilizers in a transparent bag or binding them with a binding device, and the assembly 20 can be manufactured at low cost, which is advantageous in reducing the cost of drug volatilizers 10 using multiple drug volatilizers 16 and in increasing the sales volume of drug volatilizers 10 using multiple drug volatilizers 16. Furthermore, since the assembly 20 is formed from a single sheet of cardboard 22 extending on a plane, it is not bulky and does not require a large space to be secured, so it can be easily inserted into a box together with the container 14, allowing the size of the packaging box to be minimized, which is advantageous in reducing the cost of the drug volatilizer 10 and in increasing the sales volume of drug volatilizers 10 that use multiple drug volatilizers 16.

[0018] Although the present inventors have further considered the configuration of the detachment portion 24, the present invention achieves the object and effect of the present invention, namely, that an assembly 20 can be manufactured easily and reliably at low cost, without the drug volatilizer 16 breaking apart due to vibrations or impacts during manufacturing or transportation, and that the drug volatilizer 16 can be smoothly detached from the assembly 20. That is, if the length of the connecting portion 24A along the length L direction is large, when the connecting portion 24A is cut off, the unevenness caused by the breaking of the connecting portion 24A becomes noticeable. However, since the drug volatilizer 16 is used by inserting one side in the length L direction into the inside of the container 14, if a connection part 24A is provided at the location of the drug volatilizer 16 that is inserted into the container 14, even if the length of the connection part 24A along the length L direction is increased, the unevenness caused by the breakage of the connection part 24A will be less noticeable. For this reason, the inventors carried out various tests in which the thickness of the cardboard 22 was 0.5 mm.

[0019] In the assembly 20 shown in Figure 3(A), a connection portion 24A having a length of 0.5 mm is provided 1 mm away from one end of the drug volatilizer 16 inserted into the container 14 in the length L direction, and a connection portion 24A having a length of 0.5 mm is provided 58 mm away from this connection portion 24A (a point 1 / 3 of the length L of the drug volatilizer 16 from one end), and a separation portion 24 is provided with a cut 24B at the location other than the connection portion 24A. That is, a plurality of connection parts 24A are provided only at the location of the drug volatilizer 16 that is inserted into the container 14. According to the assembly 20 shown in Figure 3(A), the drug volatilizer 16 can be smoothly separated from the assembly 20, and the connecting portion 24A will not break due to vibrations or impacts during manufacturing or transportation, preventing the assembly 20 from coming apart.Since both connecting portions 24A are located at the locations of the drug volatilizer 16 that are inserted into the container 14, the unevenness caused by the breaking of the connecting portion 24A is not noticeable.

[0020] In the assembly 20 shown in Figure 3 (B), a connection portion 24A having a length of 0.5 mm is provided at one end in the length L direction of the drug volatilizer 16 to be inserted into the container 14, a connection portion 24A having a length of 0.4 mm is provided at a location 59.5 mm away from the connection portion 24A toward one end in the length L direction (a location 1 / 3 of the length L of the drug volatilizer 16 from one end), and a connection portion 24A having a length of 0.3 mm is provided at a location 20 mm away from the other end in the length L direction toward the other end, and a separation portion 24 is provided with a cut 24B at the location other than the connection portion 24A. In other words, in the assembly 20 shown in Figure 3 (B), multiple connection portions 24A are provided at the location of the drug volatilizer 16 that is inserted into the container 14, and connection portions 24A that are shorter in length than the connection portions 24A that are provided at the location of the drug volatilizer 16 that is inserted into the container 14 are provided at the location of the drug volatilizer 16 that protrudes from the container 14. According to the assembly 20 shown in Figure 3 (B), the drug volatilizer 16 can be smoothly separated from the assembly 20, and the assembly 20 can be prevented from coming apart due to vibrations or impacts during manufacturing or transportation. Since the two connecting portions 24A are provided at the location of the drug volatilizer 16 that is inserted into the container 14, unevenness caused by the rupture of the connecting portions 24A is not noticeable. Furthermore, since the connecting portion 24A provided at the location of the drug volatilizer 16 that protrudes from the container 14 is only 0.3 mm long, unevenness caused by the rupture of the connecting portion 24A is not noticeable. In the assembly 20 shown in Figure 3(B), a connection portion 24A is also provided on the other end side in the length L direction of the drug volatilizer 16 protruding from the container 14, which is advantageous in maintaining a more stable arrangement of multiple drug volatilizers 16 compared to the assembly 20 shown in Figure 3(A) and in preventing the drug volatilizers 16 from spreading out in a fan-like manner. In addition, in the assembly 20 shown in Figures 3(A) and (B), a connecting portion 24A having a length of 0.5 mm, which is greater than 0.3 mm, is provided at one end of the drug volatilizer 16 in the length L direction, and connecting portions 24A having lengths of 0.5 mm and 0.4 mm, which are greater than 0.3 mm, are provided at locations 1 / 3 of the length L of the drug volatilizer 16 from the one end.This is because, when the drug volatilizer 10 is in use, the unevenness caused by the rupture of these connecting portions 24A is inserted into the inside of the container 14 and is difficult to see from the outside even if the container 14 is transparent.

[0021] In the assembly 20 shown in Figure 5, three connection portions 24A of 0.5 mm length are provided at intervals of 19.5 mm from one end of the drug volatilizer 16 inserted into the container 14 in the length L direction, and a separation portion 24 is provided with a cut 24B at the location other than the three connection portions 24A. The three connection parts 24A are provided at the locations where the drug volatilizer 16 is inserted into the container 14. The assembly 20 shown in Figure 5 can prevent the assembly 20 from coming apart due to vibration and impact during manufacturing and distribution in the market, and the drug volatilizer 16 can be smoothly separated from the assembly 20.Since all three connecting parts 24A are located at the points where the drug volatilizer 16 is inserted into the container 14, the unevenness caused by the rupture of the connecting parts 24A is not noticeable.

[0022] In the assembly 20 shown in Figure 6(A), a connection portion 24A having a length of 0.3 mm is provided at one end in the length L direction of the drug volatilizer 16 inserted into the container 14, and a connection portion 24A having a length of 0.3 mm is provided at a location 59.7 mm away from the connection portion 24A toward one end in the length L direction (a location 1 / 3 of the length L of the drug volatilizer 16 from the one end), and a separation portion 24 is provided with a cut 24B at the location other than the connection portion 24A. The assembly 20 shown in Figure 6(A) can also be prevented from coming apart due to vibration and impact during manufacturing and distribution in the market, and the drug volatilizer 16 can be smoothly separated from the assembly 20.Since the two connecting parts 24A are all located at the points of the drug volatilizer 16 that are inserted into the container 14, the unevenness caused by the rupture of the connecting parts 24A is not noticeable.

[0023] In the assembly 20 shown in Figure 6(B), a separation portion 24 is provided in which a connection portion 24A of 0.3 mm in length is added to the connection portions 24A, 24A of the assembly 20 shown in Figure 6(A) at a location 20 mm away from the other end in the length L direction and closer to the other end. The length of the added connection portion 24A was set to 0.3 mm because the added connection portion 24A is located above the container 14, and the unevenness caused by the breakage of the connection portion 24A is to be inconspicuous. The assembly 20 shown in Figure 6(B) also allows the drug volatilizers 16 to be smoothly separated from the assembly 20. The assembly 20 shown in Figure 6(B) is configured by adding a connection part 24A to the assembly 20 shown in Figure 6(A) at the location of the drug volatilizer 16 located above the container 14. Therefore, compared to the assembly 20 shown in Figure 6(A), this maintains the arrangement of multiple drug volatilizers 16 in a more stable state, which is advantageous in preventing the drug volatilizers 16 from spreading out like a fan, and is more advantageous in preventing the assembly 20 from coming apart.

[0024] In the cut-off portion 24 of the assembly 20 shown in FIG. 7(A), the length of the lowermost connecting portion 24A of the assembly 20 shown in FIG. 6(B) is changed from 0.3 mm to 0.5 mm. The assembly 20 shown in Figure 7(A) also allows the drug volatilizers 16 to be smoothly separated from the assembly 20. The assembly 20 shown in Figure 7(A) has a configuration in which the length of the connection portion 24A at the part of the drug volatilizer 16 that is inserted into the container 14 has been changed from 0.3 mm to 0.5 mm compared to the assembly 20 shown in Figure 6(B). Therefore, compared to the assembly 20 shown in Figure 6(B), the arrangement of multiple drug volatilizers 16 can be maintained in a more stable state, which is more advantageous in preventing the assembly 20 from coming apart. The detachment portion 24 of the assembly 20 shown in Figure 7(B) has a 0.3 mm long connection portion 24A added to the middle of the lowest connection portion 24A shown in Figure 7(A) and the connection portion 24A located 1 / 3 of the length L of the drug volatilizer 16 from one end; in other words, a 0.3 mm long connection portion 24A has been added to the location of the drug volatilizer 16 that is inserted into the container 14. The assembly 20 shown in Figure 7(B) also allows the drug volatilizer 16 to be smoothly separated from the assembly 20. The assembly 20 shown in Figure 7(B) is configured by adding a connection portion 24A having a length of 0.3 mm to the assembly 20 shown in Figure 7(A) at the location of the drug volatilizer 16 that is inserted into the container 14. Therefore, compared to the assembly 20 shown in Figure 7(A), the assembly 20 is more advantageous in maintaining the multiple drug volatilizers 16 arranged in a more stable state and preventing the assembly 20 from coming apart.

[0025] The strength of the connection part 24A connecting adjacent drug volatilizers 16 increases as the cross-sectional area of ​​the connection part 24A increases, and decreases as the cross-sectional area decreases.Therefore, the strength of the connection part 24A is proportional to the length and thickness of the drug volatilizer 16, and the greater the strength of the connection part 24A, the more noticeable the unevenness that occurs when it breaks. Therefore, when providing a connection 24A between the portion of the drug volatilizer 16 inserted into the container 14 and the portion of the drug volatilizer 16 protruding from the container 14, it is preferable that the length of the connection 24A provided at the portion of the drug volatilizer 16 protruding from the container 14 be shorter than the length of the connection 24A provided at the portion of the drug volatilizer 16 inserted into the container 14, in order to make the unevenness that occurs when the drug volatilizer 16 is broken less noticeable. In this embodiment, the thickness T of the medicine volatilizer 16 is 0.5 mm, so the connecting parts 24A having lengths of 0.5 mm, 0.4 mm, and 0.3 mm were used. The thickness T of the drug volatilizer used in the present invention is 0.3 mm to 1 mm, and if the thickness T is less than 0.5 mm, the length of the connecting portion 24A will be greater than the above-mentioned value, and if the thickness T is greater than 0.5 mm, the length of the connecting portion 24A will be less than the above-mentioned value. Therefore, when the thickness T of the medicinal volatilizer is about 0.4 mm to 0.6 mm, it is preferable that the length along the length L direction of the connecting portion 24A be appropriately selected from the range of about 0.3 mm to 0.5 mm.

[0026] It has been found that the assembly 20 having the detachment portion 24 of this embodiment makes it easy to detach the drug volatilizer 16 from the assembly 20, and that the connection portion 26A will not break due to vibrations or impacts during manufacturing or transportation, preventing the assembly 20 from falling apart.However, in addition to the assembly 20 of this embodiment, various shapes of detachment portion 24 that achieve the same effect can be considered, for example, by increasing the number of connection portions 24A that are 0.3 mm long, and the present invention is of course applicable to assembly 20 having these various shapes of detachment portion 24. Furthermore, in the above embodiment, the case where an aggregate 20 of multiple drug volatilizers 16 extends in a straight line has been described, but the extension direction of the drug volatilizers 16 is not limited to a straight line, and the aggregate 20 of multiple drug volatilizers 16 may extend in an S-shape as shown in Figure 8(A), or the aggregate 20 of multiple drug volatilizers 16 may extend in a curved shape as shown in Figure 8(B), in which case the detachment portion 24 will also extend in an S-shape or a curved shape, etc. When the drug volatilizer 16 extends in a curved or S-shaped manner, a larger surface area of ​​the drug volatilizer 16 can be secured compared to when the drug volatilizer 16 extends in a straight line, which is advantageous in increasing the volatilization effect of the drug 12. [Explanation of symbols]

[0027] 10 Chemical vaporizer 12 Drugs 12A Air Freshener 14 Container 1402 large diameter section 1404 Small diameter section 1406 Aperture 16 Drug volatiles 18 Design 20 Aggregate 2002 Short Side 2004 Long Side 22, 2202 cardboard 24 Separation section 24A connection 24B Break

Claims

1. An assembly of a plurality of rod-shaped drug volatilizers that volatilize a drug, the assembly is formed of a single substrate in the form of a thin plate, The plurality of chemical volatilizers are arranged in the base body in a direction perpendicular to the longitudinal direction with their longitudinal directions parallel to each other, Adjacent drug volatilizers are connected by detachable detachable portions, The separation portion includes a breakable connection portion that connects adjacent drug volatilizers to each other, and a slit that separates adjacent drug volatilizers from each other, The plurality of rod-shaped drug volatilizers are used as a drug volatilizer in which one end side of the drug volatilizer in the length direction is inserted into a container containing a volatile drug, and the other end side of the drug volatilizer in the length direction protrudes above the container, The connection part is provided at the location of the drug volatilizer inserted into the container, A collection of multiple rod-shaped drug volatilizers.

2. The connection portion is provided only at the location of the drug volatilizer that is inserted into the container.

2. A collection of a plurality of rod-shaped drug volatilizers according to claim 1.

3. The connection portion is provided at two locations: at the end of the drug volatilizer in the longitudinal direction, and at a location 1 / 3 of the total length of the drug volatilizer from the end of the drug volatilizer in the longitudinal direction; When the thickness of the drug volatilization body is 0.4 mm to 0.6 mm, The lengths of the two connecting portions along the longitudinal direction of the drug volatilizer are both about 0.5 mm.

3. A collection of a plurality of rod-shaped chemical volatilizers according to claim 2.

4. The connection portion is provided at a portion of the drug volatilizer inserted into the container and a portion of the drug volatilizer protruding from the container, The length of the connecting portion provided at the location of the drug volatilizer protruding from the container along the longitudinal direction of the drug volatilizer is shorter than the length of the connecting portion provided at the location of the drug volatilizer inserted into the container along the longitudinal direction of the drug volatilizer.

2. A collection of a plurality of rod-shaped drug volatilizers according to claim 1.

5. The connection portion provided at the location of the drug volatilizer inserted into the container is provided at two locations: one end of the drug volatilizer in the longitudinal direction, and one end of the drug volatilizer in the longitudinal direction, which is 1 / 3 of the total length of the drug volatilizer; The connection portion provided at the location of the drug volatilizer protruding from the container is provided at one location near the other end of the drug volatilizer in the length direction, When the thickness of the drug volatilization body is 0.4 mm to 0.6 mm, The length of the connection part provided at one end of the drug volatilizer inserted into the container in the longitudinal direction is about 0.5 mm, The length of the connecting portion inserted into the container and provided at a position 1 / 3 of the total length of the drug volatilizer from the one end is about 0.4 mm, The length of the connecting portion provided at the other end of the drug volatilizer protruding from the container in the longitudinal direction is about 0.3 mm.

5. A collection of a plurality of rod-shaped drug volatilizers according to claim 4.

6. The cross section of the drug volatilizer cut along a plane perpendicular to its length direction has a flat rectangular shape with a width greater than a thickness, The plurality of drug volatilizers are arranged such that the side surfaces of the drug volatilizers located at both ends in the width direction face each other, The separation portion connects the opposing side surfaces.

2. A collection of a plurality of rod-shaped drug volatilizers according to claim 1.

7. The substrate has a rectangular shape in a plan view, The plurality of drug volatilizing bodies are arranged on the base via the separation portions, and both ends of the plurality of drug volatilizing bodies in the longitudinal direction are located on a pair of short sides of the rectangle.

7. A collection of a plurality of rod-shaped drug volatilizers according to claim 6.

8. The drug volatilizer is made of cardboard, The substrate is formed of cardboard.

8. A collection of a plurality of rod-shaped drug volatilizers according to claim 7.

Images